Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 79 pseudogene (RNU7-79P) is classified as a human pseudogene, meaning it is a genomic sequence similar to the functional U7 small nuclear RNA gene but is not transcribed into a functional RNA or protein product[1][6][7]. Functional U7 small nuclear RNA (U7 snRNA) is an essential component of the U7 small nuclear ribonucleoprotein (snRNP) complex, which plays a critical role in the 3' end processing of replication-dependent histone pre-mRNAs[4][5]. However, as a pseudogene, RNU7-79P lacks this biological activity and is generally considered inert, with no known functional, diagnostic, or therapeutic significance[1][6][7]. Key points: The presence of "pseudogene" in its name signals that RNU7-79P is not an active molecular target. The functional homolog (RNU7-1, RNA, U7 small nuclear 1) is involved in histone mRNA processing, but RNU7-79P is not. No evidence exists regarding a role for RNU7-79P in disease, drug targeting, or as a biomarker[1][6][7]. If you are searching for a therapeutically relevant U7 small nuclear RNA, you should refer to the functional gene (e.g., RNU7-1, RNA, U7 small nuclear 1)[2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 79 pseudogene (RNU7-79P).